front 1 Pharmakon | back 1 Is greek for drugs |
front 2 Logos | back 2 is Greek for science |
front 3 What is pharmacology | back 3 Deals with the study of drugs and their actions or effects |
front 4 What are therapeutic methods to treating illnesses | back 4 diet therapy, drug therapy, Physiotherapy, Psychotherapy, |
front 5 biologic therapy | back 5 A new class of drugs has transformed treatment in patients that attack the body with its own organs tissues and cells ex cancer medication |
front 6 what is a biologic agent | back 6 Are large complex proteins manufactured in a living system |
front 7 When a drug name is not capatilize is it the generic version or the brand name. | back 7 It is the generic version |
front 8 When a drug name is Capitalized is it The generic version or The Brand name. | back 8 It is the brand name |
front 9 Which names of a drug should the nurse use when teaching a patient about a new prescription? | back 9 generic name and trade |
front 10 Body systems classification | back 10 Cardiovascular and gastro intestinal |
front 11 Therapeutic use | back 11 antacids antibiotics |
front 12 Psychological or chemical reaction | back 12 anticholinergics/ calcium channel blockers |
front 13 where can you get resources for drug information | back 13 The united states pharmacopeia/ the Usp dictionary package inserts, Nursing Journals, electronic data base |
front 14 Which source of information is best for the nurse to obtain drug information? | back 14 Nursing journals |
front 15 Where can you get sommon sources of drug information | back 15 electronic databases Lexicomp ePocrates DailyMed |
front 16 what is the controlled substance act of 1970 | back 16 The controlled substance act of 1970 is the classifacations or schedules of controlled substance |
front 17 schedule I drug | back 17 high abuse potetial ex heroin |
front 18 schedule II | back 18 high abuse potential; some medical use (e.g., pentobarbital). |
front 19 Schedule III | back 19 High abuse potential; some medical use (e.g., codeine) |
front 20 schedule IV | back 20 Low abuse potential; some medical use (e.g., diazepam). |
front 21 schedule v | back 21 low abuse potential ex Robitussin |
front 22 Which is responsible for monitoring the drug safety in the united states | back 22 The FDA is responsible for overseeing drug and cosmetic manufacture and promotion to determine their safety before allowing them to be released to the public. |
front 23 which drug schedule indicates drugs with highest risk for abuse? | back 23 Schedule I drugs have the highest potential for abuse. They are not currently accepted for medical use in the United States. |
front 24 manufactures and prescribes must do what? | back 24 The must be registered with Dea requirements must be met in order to dispense scheduled medications |
front 25 What must a person have to have in order to get scheduled drugs ? | back 25 Prescription drugs require an order by a health professional who is licensed to prescribe drugs; nonprescription (over-the-counter [OTC]) drugs are sold without a prescription. |
front 26 HOw many years does it take to bring a new drug to the market | back 26 It currently takes an average of 8 to 15 years and more than $2 billion in research and development costs to bring a single new drug to market. |
front 27 What is fast tracking | back 27 Used to expedite drug development and approval for life-threatening illnesses |
front 28 Parallel tracking | back 28 Used for patients with life-threatening illnesses who cannot participate in controlled trials, when there is no other alternative |
front 29 What is postmarking survelance stage | back 29 ongoing review of effects of new drugs |
front 30 What is black box warning | back 30 Indicates a very serious life-threatening problem Probability of a drug acquiring a new black box warning or being withdrawn from the market within 25 years of being released is 20% |
front 31 orphan drug what are they ? | back 31 They are created for rare conditions ex sickle cell anemia |
front 32 Specific sites where drugs form chemical bonds | back 32 Drug receptors |
front 33 Study of interactions between drugs and their receptors and the series of events that result in a pharmacologic response | back 33 Pharmacodynamics |
front 34 Agonists | back 34 Drugs that interact with a receptor to stimulate a response |
front 35 Drugs that attach to a receptor but do not stimulate a response | back 35 Antagonist |
front 36 Partial agonists | back 36 Drugs that interact with a receptor to stimulate a response but inhibit |
front 37 Enteral | back 37 Via the gastrointestinal tract by the oral, rectal, or nasogastric routes |
front 38 Parenteral | back 38 Bypasses the GI tract by using subcutaneous, intramuscular, and intravenous injection |
front 39 Percutaneous | back 39 Absorbed through the skin and mucous membranes Inhalation, sublingual, or topical |
front 40 ladme | back 40 Liberation: Drug released from dosage form Absorption: Depends on route of administration Distribution: Depends on circulation to be transported throughout body Metabolism: Depends on enzyme systems Excretion: Depends on GI tract and kidneys |
front 41 A drug which cannot pass through the blood-brain barrier would not be effective in treating meningitis, a brain infection. A drug which CAN pass through the placental barrier could affect the fetus. | back 41 no data |
front 42 liberation | back 42 Drug released from dosage form and is dissolved in body fluid |
front 43 Idiosyncratic reactions | back 43 Occur when something unusual/abnormal happens when drug is first administered |
front 44 Allergic reactions | back 44 Occur among patients who have previously been exposed to a drug and whose immune systems have developed antibodies to the drug |
front 45 Drug Interactions | back 45 Said to occur when the action of one drug is altered or changed by the action of another drug |
front 46 Changes in Absorption | back 46 Most drug interactions that alter absorption take place in the GI tract Antacids increase the gastric pH and can inhibit the dissolution of ketoconazole tablets |
front 47 Changes in Distribution | back 47 If a drug is 90% bound to a protein, then 10% of the drug is providing the physiologic effect. |
front 48 Changes in Metabolism | back 48 Drug interactions usually result from a change in metabolism that involves inhibiting or inducing the enzymes that metabolize a drug |
front 49 Common drugs that bind to enzymes and increase the metabolism of other drugs are | back 49 phenobarbital, carbamazepine, rifampin, and phenytoin. |
front 50 Changes in Excretion | back 50 Drug interactions that cause a change in excretion usually act in the kidney tubules by changing the pH to enhance or inhibit excretion |
front 51 A patient reports postoperative pain, and the nurse administers IV morphine (a narcotic analgesic) to ease the pain. Fifteen minutes later, the nurse notes that the patient is very drowsy, respirations are slow and shallow, and oxygen saturation is low. The nurse administers another drug that decreases the morphine’s action. What is this effect called? | back 51 Antagonistic |